 | • レポートコード：QYR2104Z5855 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ワクチン＆ワクチン接種のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、トキソイドワクチン、合成ワクチン、樹状細胞ワクチン）、用途別市場規模（乳幼児用ワクチン、成人用特別ワクチン、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ワクチン＆ワクチン接種の市場動向 ・企業の競争状況、市場シェア ・ワクチン＆ワクチン接種の種類別市場規模（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、トキソイドワクチン、合成ワクチン、樹状細胞ワクチン） ・ワクチン＆ワクチン接種の用途別市場規模（乳幼児用ワクチン、成人用特別ワクチン、その他） ・ワクチン＆ワクチン接種の北米市場規模2016-2027（アメリカ、カナダ） ・ワクチン＆ワクチン接種のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ワクチン＆ワクチン接種のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ワクチン＆ワクチン接種の中南米市場規模2016-2027（メキシコ、ブラジル） ・ワクチン＆ワクチン接種の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、AstraZeneca、Bavarian Nordic、Novartis、Bharat Biotech、Bio-Med、CSL、Emergent BioSolutions、GSK、Johnson & Johnson、Pfizer、Merck、Sanofi） ・結論 |
Market Analysis and Insights: Global Vaccines & Vaccination Market
The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccines & Vaccination market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccines & Vaccination market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccines & Vaccination market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccines & Vaccination market.
Global Vaccines & Vaccination Scope and Market Size
Vaccines & Vaccination market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines & Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Novartis
Bharat Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2016-2027)
2.2 Vaccines & Vaccination Growth Trends by Regions
2.2.1 Vaccines & Vaccination Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaccines & Vaccination Historic Market Share by Regions (2016-2021)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Regions (2022-2027)
2.3 Vaccines & Vaccination Industry Dynamic
2.3.1 Vaccines & Vaccination Market Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2016-2021)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2016-2021)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2020
3.5 Vaccines & Vaccination Key Players Head office and Area Served
3.6 Key Players Vaccines & Vaccination Product Solution and Service
3.7 Date of Enter into Vaccines & Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2016-2021)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2022-2027)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2016-2021)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2016-2027)
6.2 North America Vaccines & Vaccination Market Size by Type
6.2.1 North America Vaccines & Vaccination Market Size by Type (2016-2021)
6.2.2 North America Vaccines & Vaccination Market Size by Type (2022-2027)
6.2.3 North America Vaccines & Vaccination Market Size by Type (2016-2027)
6.3 North America Vaccines & Vaccination Market Size by Application
6.3.1 North America Vaccines & Vaccination Market Size by Application (2016-2021)
6.3.2 North America Vaccines & Vaccination Market Size by Application (2022-2027)
6.3.3 North America Vaccines & Vaccination Market Size by Application (2016-2027)
6.4 North America Vaccines & Vaccination Market Size by Country
6.4.1 North America Vaccines & Vaccination Market Size by Country (2016-2021)
6.4.2 North America Vaccines & Vaccination Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2016-2027)
7.2 Europe Vaccines & Vaccination Market Size by Type
7.2.1 Europe Vaccines & Vaccination Market Size by Type (2016-2021)
7.2.2 Europe Vaccines & Vaccination Market Size by Type (2022-2027)
7.2.3 Europe Vaccines & Vaccination Market Size by Type (2016-2027)
7.3 Europe Vaccines & Vaccination Market Size by Application
7.3.1 Europe Vaccines & Vaccination Market Size by Application (2016-2021)
7.3.2 Europe Vaccines & Vaccination Market Size by Application (2022-2027)
7.3.3 Europe Vaccines & Vaccination Market Size by Application (2016-2027)
7.4 Europe Vaccines & Vaccination Market Size by Country
7.4.1 Europe Vaccines & Vaccination Market Size by Country (2016-2021)
7.4.2 Europe Vaccines & Vaccination Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2016-2027)
8.2 Asia-Pacific Vaccines & Vaccination Market Size by Type
8.2.1 Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaccines & Vaccination Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Application
8.3.1 Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaccines & Vaccination Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaccines & Vaccination Market Size by Region
8.4.1 Asia-Pacific Vaccines & Vaccination Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaccines & Vaccination Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2016-2027)
9.2 Latin America Vaccines & Vaccination Market Size by Type
9.2.1 Latin America Vaccines & Vaccination Market Size by Type (2016-2021)
9.2.2 Latin America Vaccines & Vaccination Market Size by Type (2022-2027)
9.2.3 Latin America Vaccines & Vaccination Market Size by Type (2016-2027)
9.3 Latin America Vaccines & Vaccination Market Size by Application
9.3.1 Latin America Vaccines & Vaccination Market Size by Application (2016-2021)
9.3.2 Latin America Vaccines & Vaccination Market Size by Application (2022-2027)
9.3.3 Latin America Vaccines & Vaccination Market Size by Application (2016-2027)
9.4 Latin America Vaccines & Vaccination Market Size by Country
9.4.1 Latin America Vaccines & Vaccination Market Size by Country (2016-2021)
9.4.2 Latin America Vaccines & Vaccination Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2016-2027)
10.2 Middle East & Africa Vaccines & Vaccination Market Size by Type
10.2.1 Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaccines & Vaccination Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Application
10.3.1 Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaccines & Vaccination Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaccines & Vaccination Market Size by Country
10.4.1 Middle East & Africa Vaccines & Vaccination Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaccines & Vaccination Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Details
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2016-2021)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Details
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2016-2021)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Details
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2016-2021)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Details
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2016-2021)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Details
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2016-2021)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2016-2021)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2016-2021)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2016-2021)
11.13.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Subunit vaccines
Table 3. Key Players of Live attenuated vaccines
Table 4. Key Players of Conjugate vaccines
Table 5. Key Players of Inactivated vaccines
Table 6. Key Players of Recombinant vector vaccines
Table 7. Key Players of Toxoid vaccines
Table 8. Key Players of Synthetic vaccines
Table 9. Key Players of Dendritic cell vaccines
Table 10. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Vaccines & Vaccination Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Vaccines & Vaccination Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Vaccines & Vaccination Market Share by Regions (2016-2021)
Table 14. Global Vaccines & Vaccination Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Vaccines & Vaccination Market Share by Regions (2022-2027)
Table 16. Vaccines & Vaccination Market Trends
Table 17. Vaccines & Vaccination Market Drivers
Table 18. Vaccines & Vaccination Market Challenges
Table 19. Vaccines & Vaccination Market Restraints
Table 20. Global Vaccines & Vaccination Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Vaccines & Vaccination Market Share by Players (2016-2021)
Table 22. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2020)
Table 23. Ranking of Global Top Vaccines & Vaccination Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Vaccines & Vaccination Product Solution and Service
Table 27. Date of Enter into Vaccines & Vaccination Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Vaccines & Vaccination Revenue Market Share by Type (2016-2021)
Table 31. Global Vaccines & Vaccination Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Vaccines & Vaccination Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Vaccines & Vaccination Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Vaccines & Vaccination Revenue Market Share by Application (2016-2021)
Table 35. Global Vaccines & Vaccination Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Vaccines & Vaccination Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Vaccines & Vaccination Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Vaccines & Vaccination Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Vaccines & Vaccination Product
Table 70. Abbott Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Vaccines & Vaccination Product
Table 75. AstraZeneca Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Bavarian Nordic Company Details
Table 78. Bavarian Nordic Business Overview
Table 79. Bavarian Nordic Vaccines & Vaccination Product
Table 80. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 81. Bavarian Nordic Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Vaccines & Vaccination Product
Table 85. Novartis Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Bharat Biotech Company Details
Table 88. Bharat Biotech Business Overview
Table 89. Bharat Biotech Vaccines & Vaccination Product
Table 90. Bharat Biotech Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 91. Bharat Biotech Recent Development
Table 92. Bio-Med Company Details
Table 93. Bio-Med Business Overview
Table 94. Bio-Med Vaccines & Vaccination Product
Table 95. Bio-Med Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 96. Bio-Med Recent Development
Table 97. CSL Company Details
Table 98. CSL Business Overview
Table 99. CSL Vaccines & Vaccination Product
Table 100. CSL Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 101. CSL Recent Development
Table 102. Emergent BioSolutions Company Details
Table 103. Emergent BioSolutions Business Overview
Table 104. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 105. Emergent BioSolutions Recent Development
Table 106. GSK Company Details
Table 107. GSK Business Overview
Table 108. GSK Vaccines & Vaccination Product
Table 109. GSK Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 110. GSK Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Vaccines & Vaccination Product
Table 114. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Vaccines & Vaccination Product
Table 119. Pfizer Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 120. Pfizer Recent Development
Table 121. Merck Company Details
Table 122. Merck Business Overview
Table 123. Merck Vaccines & Vaccination Product
Table 124. Merck Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 125. Merck Recent Development
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Vaccines & Vaccination Product
Table 129. Sanofi Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 130. Sanofi Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccines & Vaccination Market Share by Type: 2020 VS 2027
Figure 2. Subunit vaccines Features
Figure 3. Live attenuated vaccines Features
Figure 4. Conjugate vaccines Features
Figure 5. Inactivated vaccines Features
Figure 6. Recombinant vector vaccines Features
Figure 7. Toxoid vaccines Features
Figure 8. Synthetic vaccines Features
Figure 9. Dendritic cell vaccines Features
Figure 10. Global Vaccines & Vaccination Market Share by Application: 2020 VS 2027
Figure 11. Baby Vaccine Case Studies
Figure 12. Adult Special Vaccine Case Studies
Figure 13. Other Case Studies
Figure 14. Vaccines & Vaccination Report Years Considered
Figure 15. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Vaccines & Vaccination Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Vaccines & Vaccination Market Share by Regions: 2020 VS 2027
Figure 18. Global Vaccines & Vaccination Market Share by Regions (2022-2027)
Figure 19. Global Vaccines & Vaccination Market Share by Players in 2020
Figure 20. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2020
Figure 22. Global Vaccines & Vaccination Revenue Market Share by Type (2016-2021)
Figure 23. Global Vaccines & Vaccination Revenue Market Share by Type (2022-2027)
Figure 24. North America Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 26. North America Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 27. North America Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 28. United States Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 32. Europe Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 33. Europe Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 34. Germany Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Vaccines & Vaccination Market Share by Region (2016-2027)
Figure 44. China Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 52. Latin America Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 53. Latin America Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 54. Mexico Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 60. Turkey Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 65. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 67. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 68. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 69. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 70. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 71. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 73. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 75. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の細菌ワクチン市場規模・現状・予測（2021年-2027年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…- 世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…
- 世界の組換えワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のワクチン配達市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…